EUVIMEDEUVIMED entdecken
Crossref

Apixaban Versus Enoxaparin For Postoperative Thromboprophylaxis

Mr. A. Prathap, Mounisha R, Krupadevi G, Lavanya E, Manisha T

International Journal of Enhanced Research in Medicines & Dental Care · 2026

DOI: 10.55948/ijermdc.13102601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Enhanced Research in Medicines & Dental Care, 2026. Verfasst von Mr. A. Prathap und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major complication following surgery. Pharmacological thromboprophylaxis is essential for reducing VTE risk. Enoxaparin, a low-molecular-weight heparin, is widely used, while apixaban provides an oral direct factor Xa inhibitor alternative.

Objective

To compare the efficacy, safety, advantages, and limitations of apixaban and enoxaparin for postoperative thromboprophylaxis.

Methods

Evidence from randomized controlled trials, comparative studies, systematic reviews, and clinical guidelines was reviewed, focusing on VTE prevention, bleeding outcomes, route of administration, renal function, treatment duration, and patient-related factors.

Results

Apixaban demonstrated effective VTE prevention with efficacy and bleeding outcomes broadly comparable to enoxaparin, particularly after major orthopedic surgery. Its oral administration offers greater convenience than subcutaneous enoxaparin.

Conclusion

Apixaban is an effective oral option in appropriately selected patients. Treatment should be individualized according to surgical procedure, thrombotic and bleeding risks, renal function, and current guidelines.

Zitieren

APA

Prathap, M. A., R, M., G, K., E, L., & T, M. (2026). Apixaban Versus Enoxaparin For Postoperative Thromboprophylaxis. International Journal of Enhanced Research in Medicines & Dental Care. https://doi.org/10.55948/ijermdc.13102601

Vancouver

Prathap MA, R M, G K, E L, T M. Apixaban Versus Enoxaparin For Postoperative Thromboprophylaxis. International Journal of Enhanced Research in Medicines & Dental Care. 2026. doi:10.55948/ijermdc.13102601

BibTeX
@article{Prathap2026,
  author = {Prathap, Mr. A. and R, Mounisha and G, Krupadevi and E, Lavanya and T, Manisha},
  title = {Apixaban Versus Enoxaparin For Postoperative Thromboprophylaxis},
  journal = {International Journal of Enhanced Research in Medicines & Dental Care},
  year = {2026},
  doi = {10.55948/ijermdc.13102601}
}
Kostenlos starten →